Biodesix Inc (BDSX) bonds
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$9.88+0.09 (+0.92%)
Close on Nov 13, 2026Market cap $104.25MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Total debt
$47.15M
Long-term debt
Net debt
$18.74M
After $28.41M of cash
Implied interest rate
18.40%
FY2025 interest ÷ average debt
Interest coverage
-3.6×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Biodesix's 10-Q for the period ended Nov 21, 2027
| Issue | Coupon | Matures | Carrying value |
|---|---|---|---|
| Perceptive Term Loan Facility | 3.00% | Nov 21, 2027 | – |
| Other | – | – | $6.00K |
| Perceptive Term Loan Facility | – | – | $50.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?